| Tolerance to changes in membrane lipid composition as a selected trait of membrane proteins CR Sanders, KF Mittendorf Biochemistry 50 (37), 7858-7867, 2011 | 105 | 2011 |
| Returning integrated genomic risk and clinical recommendations: The eMERGE study JE Linder, A Allworth, HT Bland, PJ Caraballo, RL Chisholm, EW Clayton, ... Genetics in Medicine 25 (4), 100006, 2023 | 72 | 2023 |
| Peripheral myelin protein 22 alters membrane architecture KF Mittendorf, JT Marinko, CM Hampton, Z Ke, A Hadziselimovic, ... Science advances 3 (7), e1700220, 2017 | 72 | 2017 |
| Primary ovarian insufficiency and adolescent vaccination AL Naleway, KF Mittendorf, SA Irving, ML Henninger, B Crane, N Smith, ... Pediatrics 142 (3), 2018 | 63 | 2018 |
| Conformational stability and pathogenic misfolding of the integral membrane protein PMP22 JP Schlebach, M Narayan, C Alford, KF Mittendorf, BD Carter, J Li, ... Journal of the American Chemical Society 137 (27), 8758-8768, 2015 | 62 | 2015 |
| Impact of bilayer lipid composition on the structure and topology of the transmembrane amyloid precursor C99 protein Y Song, KF Mittendorf, Z Lu, CR Sanders Journal of the American Chemical Society 136 (11), 4093-4096, 2014 | 61 | 2014 |
| Tailoring of membrane proteins by alternative splicing of pre-mRNA KF Mittendorf, CL Deatherage, MD Ohi, CR Sanders Biochemistry 51 (28), 5541-5556, 2012 | 43 | 2012 |
| Reversible folding of human peripheral myelin protein 22, a tetraspan membrane protein JP Schlebach, D Peng, BM Kroncke, KF Mittendorf, M Narayan, BD Carter, ... Biochemistry 52 (19), 3229-3241, 2013 | 42 | 2013 |
| Bicelles rich in both sphingolipids and cholesterol and their use in studies of membrane proteins JM Hutchison, KC Shih, HA Scheidt, SM Fantin, KF Parson, ... Journal of the American Chemical Society 142 (29), 12715-12729, 2020 | 40 | 2020 |
| Evidence‐based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group EM Webber, JE Hunter, LG Biesecker, AH Buchanan, EV Clarke, E Currey, ... Human mutation 39 (11), 1677-1685, 2018 | 38 | 2018 |
| Cancer Health Assessments Reaching Many (CHARM): a clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations KF Mittendorf, TL Kauffman, LM Amendola, KP Anderson, BB Biesecker, ... Contemporary clinical trials 106, 106432, 2021 | 32 | 2021 |
| While the revolution will not be crystallized, biochemistry reigns supreme Y Takizawa, E Binshtein, AL Erwin, TM Pyburn, KF Mittendorf, MD Ohi Protein Science 26 (1), 69-81, 2017 | 32 | 2017 |
| Systemic barriers to risk-reducing interventions for hereditary cancer syndromes: implications for health care inequities KF Mittendorf, S Knerr, TL Kauffman, NM Lindberg, KP Anderson, ... JCO Precision Oncology 5, 1709-1718, 2021 | 28 | 2021 |
| The homology model of PMP22 suggests mutations resulting in peripheral neuropathy disrupt transmembrane helix packing KF Mittendorf, BM Kroncke, J Meiler, CR Sanders Biochemistry 53 (39), 6139-6141, 2014 | 25 | 2014 |
| My cancer genome: coevolution of precision oncology and a molecular oncology knowledgebase ME Holt, KF Mittendorf, M LeNoue-Newton, NM Jain, I Anderson, ... JCO Clinical Cancer Informatics 5, 995-1004, 2021 | 24 | 2021 |
| Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods study KF Mittendorf, JE Hunter, JL Schneider, E Shuster, AF Rope, J Zepp, ... Hereditary Cancer in Clinical Practice 17, 1-13, 2019 | 18 | 2019 |
| Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population KF Mittendorf, C Ukaegbu, MJ Gilmore, NM Lindberg, TL Kauffman, ... Familial cancer, 1-14, 2022 | 16 | 2022 |
| Creating accessible Spanish language materials for Clinical Sequencing Evidence-Generating Research consortium genomic projects: challenges and lessons learned NM Lindberg, AM Gutierrez, KF Mittendorf, MA Ramos, B Anguiano, ... Personalized Medicine 18 (05), 441-454, 2021 | 16 | 2021 |
| Participant reactions to a literacy-focused, web-based informed consent approach for a genomic implementation study SA Kraft, KM Porter, DM Duenas, C Guerra, G Joseph, SSJ Lee, ... AJOB empirical bioethics 12 (1), 1-11, 2021 | 16 | 2021 |
| Integration of stakeholder engagement from development to dissemination in genomic medicine research: approaches and outcomes from the CSER Consortium JM O’Daniel, S Ackerman, LR Desrosiers, S Rego, SJ Knight, L Mollison, ... Genetics in Medicine 24 (5), 1108-1119, 2022 | 15 | 2022 |
